324 related articles for article (PubMed ID: 21616283)
1. Volume status and diuretic therapy in systolic heart failure and the detection of early abnormalities in renal and tubular function.
Damman K; Ng Kam Chuen MJ; MacFadyen RJ; Lip GY; Gaze D; Collinson PO; Hillege HL; van Oeveren W; Voors AA; van Veldhuisen DJ
J Am Coll Cardiol; 2011 May; 57(22):2233-41. PubMed ID: 21616283
[TBL] [Abstract][Full Text] [Related]
2. Diuretics: are our ideas based on knowledge?
Gottlieb SS
J Am Coll Cardiol; 2011 May; 57(22):2242-3. PubMed ID: 21616284
[No Abstract] [Full Text] [Related]
3. Kidney injury molecule-1 and N-acetyl-β-D-glucosaminidase in chronic heart failure: possible biomarkers of cardiorenal syndrome.
Jungbauer CG; Birner C; Jung B; Buchner S; Lubnow M; von Bary C; Endemann D; Banas B; Mack M; Böger CA; Riegger G; Luchner A
Eur J Heart Fail; 2011 Oct; 13(10):1104-10. PubMed ID: 21846754
[TBL] [Abstract][Full Text] [Related]
4. In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function.
De Vecchis R; Ciccarelli A; Ariano C; Cioppa C; Giasi A; Pucciarelli A; Cantatrione S
Minerva Cardioangiol; 2011 Dec; 59(6):543-54. PubMed ID: 21330961
[TBL] [Abstract][Full Text] [Related]
5. Clinical outcome of renal tubular damage in chronic heart failure.
Damman K; Masson S; Hillege HL; Maggioni AP; Voors AA; Opasich C; van Veldhuisen DJ; Montagna L; Cosmi F; Tognoni G; Tavazzi L; Latini R
Eur Heart J; 2011 Nov; 32(21):2705-12. PubMed ID: 21666249
[TBL] [Abstract][Full Text] [Related]
6. N-acteyl-ß-D-glucosaminidase and kidney injury molecule-1: New predictors for long-term progression of chronic kidney disease in patients with heart failure.
Jungbauer CG; Uecer E; Stadler S; Birner C; Buchner S; Maier LS; Luchner A
Nephrology (Carlton); 2016 Jun; 21(6):490-8. PubMed ID: 26422793
[TBL] [Abstract][Full Text] [Related]
7. Worsening Renal Function in Patients With Acute Heart Failure Undergoing Aggressive Diuresis Is Not Associated With Tubular Injury.
Ahmad T; Jackson K; Rao VS; Tang WHW; Brisco-Bacik MA; Chen HH; Felker GM; Hernandez AF; O'Connor CM; Sabbisetti VS; Bonventre JV; Wilson FP; Coca SG; Testani JM
Circulation; 2018 May; 137(19):2016-2028. PubMed ID: 29352071
[TBL] [Abstract][Full Text] [Related]
8. Plasma kidney injury molecule-1 in heart failure: renal mechanisms and clinical outcome.
Emmens JE; Ter Maaten JM; Matsue Y; Metra M; O'Connor CM; Ponikowski P; Teerlink JR; Cotter G; Davison B; Cleland JG; Givertz MM; Bloomfield DM; Dittrich HC; Todd J; van Veldhuisen DJ; Hillege HL; Damman K; van der Meer P; Voors AA
Eur J Heart Fail; 2016 Jun; 18(6):641-9. PubMed ID: 26511274
[TBL] [Abstract][Full Text] [Related]
9. Effect of renin-angiotensin-aldosterone system inhibition, dietary sodium restriction, and/or diuretics on urinary kidney injury molecule 1 excretion in nondiabetic proteinuric kidney disease: a post hoc analysis of a randomized controlled trial.
Waanders F; Vaidya VS; van Goor H; Leuvenink H; Damman K; Hamming I; Bonventre JV; Vogt L; Navis G
Am J Kidney Dis; 2009 Jan; 53(1):16-25. PubMed ID: 18823687
[TBL] [Abstract][Full Text] [Related]
10. Performance of urinary kidney injury molecule-1, neutrophil gelatinase-associated lipocalin, and N-acetyl-β-D-glucosaminidase to predict chronic kidney disease progression and adverse outcomes.
Lobato GR; Lobato MR; Thomé FS; Veronese FV
Braz J Med Biol Res; 2017 Mar; 50(5):e6106. PubMed ID: 28380198
[TBL] [Abstract][Full Text] [Related]
11. Changes of the tubular markers in type 2 diabetes mellitus with glomerular hyperfiltration.
Fu WJ; Li BL; Wang SB; Chen ML; Deng RT; Ye CQ; Liu L; Fang AJ; Xiong SL; Wen S; Tang HH; Chen ZX; Huang ZH; Peng LF; Zheng L; Wang Q
Diabetes Res Clin Pract; 2012 Jan; 95(1):105-9. PubMed ID: 22015481
[TBL] [Abstract][Full Text] [Related]
12. Renal tubular function and urinary N-acetyl-β-d-glucosaminidase and kidney injury molecule-1 levels in asthmatic children.
Demir AD; Goknar N; Oktem F; Özkaya E; Yazıcı M; Torun E; Vehapoğlu A; Kucukkoc M
Int J Immunopathol Pharmacol; 2016 Dec; 29(4):626-631. PubMed ID: 27272162
[TBL] [Abstract][Full Text] [Related]
13. Establishment of reference values for novel urinary biomarkers for renal damage in the healthy population: are age and gender an issue?
Pennemans V; Rigo JM; Faes C; Reynders C; Penders J; Swennen Q
Clin Chem Lab Med; 2013 Sep; 51(9):1795-802. PubMed ID: 23648635
[TBL] [Abstract][Full Text] [Related]
14. Brain natriuretic peptide enhances renal actions of furosemide and suppresses furosemide-induced aldosterone activation in experimental heart failure.
Cataliotti A; Boerrigter G; Costello-Boerrigter LC; Schirger JA; Tsuruda T; Heublein DM; Chen HH; Malatino LS; Burnett JC
Circulation; 2004 Apr; 109(13):1680-5. PubMed ID: 15023890
[TBL] [Abstract][Full Text] [Related]
15. Poor concordance between different definitions of worsening renal function in patients with acute exacerbation of chronic heart failure: a retrospective study.
De Vecchis R; Baldi C; Di Biase G
Minerva Cardioangiol; 2016 Apr; 64(2):127-37. PubMed ID: 25423291
[TBL] [Abstract][Full Text] [Related]
16. High urinary excretion of kidney injury molecule-1 is an independent predictor of end-stage renal disease in patients with IgA nephropathy.
Peters HP; Waanders F; Meijer E; van den Brand J; Steenbergen EJ; van Goor H; Wetzels JF
Nephrol Dial Transplant; 2011 Nov; 26(11):3581-8. PubMed ID: 21467131
[TBL] [Abstract][Full Text] [Related]
17. Renal effects of added low-dose dopamine in acute heart failure patients with diuretic resistance to natriuretic peptide.
Kamiya M; Sato N; Nozaki A; Akiya M; Okazaki H; Takahashi Y; Mizuno K; Shimizu W
J Cardiovasc Pharmacol; 2015 Mar; 65(3):282-8. PubMed ID: 25748698
[TBL] [Abstract][Full Text] [Related]
18. Tubular damage in chronic systolic heart failure is associated with reduced survival independent of glomerular filtration rate.
Damman K; Van Veldhuisen DJ; Navis G; Vaidya VS; Smilde TD; Westenbrink BD; Bonventre JV; Voors AA; Hillege HL
Heart; 2010 Aug; 96(16):1297-302. PubMed ID: 20659949
[TBL] [Abstract][Full Text] [Related]
19. Urocortin 2 inhibits furosemide-induced activation of renin and enhances renal function and diuretic responsiveness in experimental heart failure.
Rademaker MT; Charles CJ; Nicholls MG; Richards AM
Circ Heart Fail; 2009 Nov; 2(6):532-40. PubMed ID: 19919977
[TBL] [Abstract][Full Text] [Related]
20. Effects of standard heart failure therapy and concomitant treatment with intravenous furosemide or inotropes (dobutamine, dopamine, and/or milrinone) on renal function and mortality in patients treated with nesiritide.
Kurien S; Warfield KT; Wood CM; Miller WL
Am J Cardiol; 2006 Dec; 98(12):1627-30. PubMed ID: 17145223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]